[go: up one dir, main page]

DK2739270T3 - Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer - Google Patents

Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer Download PDF

Info

Publication number
DK2739270T3
DK2739270T3 DK12819632.6T DK12819632T DK2739270T3 DK 2739270 T3 DK2739270 T3 DK 2739270T3 DK 12819632 T DK12819632 T DK 12819632T DK 2739270 T3 DK2739270 T3 DK 2739270T3
Authority
DK
Denmark
Prior art keywords
administrating
extendable
caps
absorbing materials
fluid absorbing
Prior art date
Application number
DK12819632.6T
Other languages
English (en)
Inventor
Danielle Berger
Original Assignee
Hb Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hb Biotechnologies Corp filed Critical Hb Biotechnologies Corp
Application granted granted Critical
Publication of DK2739270T3 publication Critical patent/DK2739270T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/721Dextrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738Cross-linked polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DK12819632.6T 2011-08-01 2012-08-01 Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer DK2739270T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161513923P 2011-08-01 2011-08-01
US201161523787P 2011-08-15 2011-08-15
PCT/US2012/049209 WO2013019891A1 (en) 2011-08-01 2012-08-01 Non-digestible capsules for the delivery of fluid absorbing materials

Publications (1)

Publication Number Publication Date
DK2739270T3 true DK2739270T3 (da) 2020-04-06

Family

ID=47629668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12819632.6T DK2739270T3 (da) 2011-08-01 2012-08-01 Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer

Country Status (16)

Country Link
US (2) US20150216808A1 (da)
EP (1) EP2739270B1 (da)
JP (2) JP2014521689A (da)
CA (1) CA2842802C (da)
CY (1) CY1123430T1 (da)
DK (1) DK2739270T3 (da)
ES (1) ES2782523T3 (da)
HR (1) HRP20200463T1 (da)
HU (1) HUE049186T2 (da)
LT (1) LT2739270T (da)
PL (1) PL2739270T3 (da)
PT (1) PT2739270T (da)
RS (1) RS60294B1 (da)
SI (1) SI2739270T1 (da)
SM (1) SMT202000161T1 (da)
WO (1) WO2013019891A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11484579B2 (en) * 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE169293C1 (da) 1958-03-13 1959-11-10
US3042667A (en) 1959-03-10 1962-07-03 Pharmacia Ab Process for producing dextran derivatives and products resulting therefrom
SE319903B (da) 1964-01-31 1970-01-26 Pharmacia Ab
US3300474A (en) 1964-02-12 1967-01-24 Pharmacia Ab Sucrose ether copolymerizates
US3518340A (en) 1968-04-15 1970-06-30 Dow Corning Method of forming silicone rubber drug carriers
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
US4470975A (en) * 1977-10-21 1984-09-11 The Johns Hopkins University Method and composition for the elimination of water from an animal body
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4663148A (en) * 1984-03-21 1987-05-05 Alza Corporation Dispenser comprising telescopically engaging members
HU207940B (en) * 1989-02-16 1993-07-28 British Tech Group Feeder apparatus for controlled dissolution of the active components
GB8903564D0 (en) * 1989-02-16 1989-04-05 Rashid Abdul Drug dispensing device
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
JP3238350B2 (ja) 1997-05-27 2001-12-10 三粧化研株式会社 可食性パール状カプセルおよびその製造法
US6908609B2 (en) * 2000-11-20 2005-06-21 Dow Global Technologies Inc. In vivo use of water absorbent polymers
AU2002242103A1 (en) * 2001-02-06 2002-08-19 Ash Medical Systems, Inc. Monovalent-selective cation exchangers as oral sorbent therapy
NO20021592D0 (no) 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
WO2004024126A1 (en) * 2002-09-13 2004-03-25 Cydex, Inc. Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
EP1537789B1 (de) * 2003-12-04 2006-09-27 Cognis IP Management GmbH Zubereitung für die orale und/oder topische Anwendung (I)
WO2005084649A1 (ja) 2004-03-04 2005-09-15 Takeda Pharmaceutical Company Limited 安定なカプセル剤
US9233075B2 (en) * 2005-08-09 2016-01-12 Metacure Limited Satiety
WO2007103186A2 (en) 2006-03-03 2007-09-13 Fmc Corporation Method and apparatus for the preparation of capsules
CA2647487C (en) * 2006-03-29 2014-10-21 Electronic Dietary Foods Inc. Ingestible implement for weight control
US20080268045A1 (en) * 2006-11-09 2008-10-30 Proprius Pharmaceuticals, Inc. Sustained release methotrexate formulations and methods of use thereof
GB0625180D0 (en) * 2006-12-15 2007-01-24 Mw Encap Ltd Improved hard shell capsules
EP2601981A1 (en) * 2007-08-29 2013-06-12 Sorbent Therapeutics, Inc. Absorbent polymeric compositions with varying counterion content and their methods of preparation and use
WO2009049105A2 (en) * 2007-10-09 2009-04-16 Gelesis, Inc. Methods for inducing satiation
US20100136070A1 (en) * 2008-12-03 2010-06-03 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
US20100291201A1 (en) * 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
US8101203B2 (en) * 2010-01-14 2012-01-24 Karl Wei Cao Hard capsule composition and method of use

Also Published As

Publication number Publication date
HUE049186T2 (hu) 2020-09-28
PL2739270T3 (pl) 2020-10-05
SMT202000161T1 (it) 2020-05-08
LT2739270T (lt) 2020-07-10
US20150216808A1 (en) 2015-08-06
EP2739270B1 (en) 2020-01-01
JP2017081973A (ja) 2017-05-18
US20210330595A1 (en) 2021-10-28
RS60294B1 (sr) 2020-07-31
EP2739270A4 (en) 2015-01-14
JP6446071B2 (ja) 2018-12-26
WO2013019891A1 (en) 2013-02-07
HRP20200463T1 (hr) 2020-06-26
CA2842802C (en) 2020-03-10
JP2014521689A (ja) 2014-08-28
EP2739270A1 (en) 2014-06-11
ES2782523T3 (es) 2020-09-15
CY1123430T1 (el) 2021-12-31
CA2842802A1 (en) 2013-02-07
PT2739270T (pt) 2020-04-02
SI2739270T1 (sl) 2020-10-30

Similar Documents

Publication Publication Date Title
DK3669913T3 (da) Anordning til indgivelse af lægemidler
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
DK2812055T3 (da) Injektionsindretning til administration eller transport af fluidprodukt
DK3639872T3 (da) Lægemiddeladministrationsanordning
PL2817052T3 (pl) Urządzenia do podawania donosowego
DK3723369T3 (da) Indretning til kortlægning af intraprædikationsmodus
EP2849792A4 (en) LIQUID FORMULATION
DK2389918T3 (da) Anordning til indgivelse af væske i næse-øre-hals-området
EP2671604A4 (en) COMBINATION TANK / SYRINGE
BR112015002662A2 (pt) dispositivo para evaporar um fluido volátil
PL2591860T3 (pl) Kapturek aktywatora dla dozownika płynu
DK2897594T3 (da) Farmaceutisk sammensætning
DK3003456T3 (da) Indretning til anvendelse af flydende lægemidler
BR112014009319A2 (pt) compostos farmacêuticos
DK2863985T3 (da) Anordning til forbedring af mikrocirkulering
DK2877677T3 (da) Strømningsbegrænser
EP2910121A4 (en) LIQUID INSECTICIDE COMPOSITION
BR112015005500A2 (pt) composto, composição farmacêutica, combinação de um composto, uso de um composto e dispositivo
EP2833959C0 (de) Fluidverbindungselement
DE112012002424A5 (de) Fluidvorrichtung
DE112013004054A5 (de) Fluidfilter
DK2739270T3 (da) Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION
LT2908836T (lt) Farmacinė kompozicija, turinti kurkumino
BR112013022907A2 (pt) composição farmacêutica